Literature DB >> 8971363

Can elevated chromium induce somatopsychic responses?

I Lovrincevic1, F Y Leung, M A Alfieri, D M Grace.   

Abstract

The possible somatopsychological effects of chromium (Cr) was investigated in a population of patients, from a surgical ward of our hospital, who required total parenteral nutrition (TPN) solutions, and who became exposed to various amounts of this metal from this treatment. The study involved a questionnaire as well as biochemical tests which included serum Cr and other selected trace metals. The renal status for all eligible patients was within normal parameters. The patient population varied in age, pathology, surgical treatment, and duration on TPN. The results showed that every patient who received TPN had an increased serum Cr level; some increases were up to 50-fold above the normal reference level for serum Cr. Although statistical analysis failed to show any significant statistical relationship between an increased serum Cr and the investigated somatopsychological disturbances, this effect cannot be ruled out since one case did show all the dream disturbances. Considering these cases, the action of sedative medications that may suppress the effects of Cr, cannot be ruled out. As Cr(III) may be potentially genotoxic at high concentrations, infusion of this metal over long time periods should be avoided. Supplementation of Cr in TPN solutions appears to be unnecessary for short-term TPN because this metal is a known contaminant of these solutions. Efforts are required to find TPN nutrients with low or no Cr contamination.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971363     DOI: 10.1007/bf02784177

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  20 in total

1.  Essential trace element provision to patients receiving home intravenous nutrition in the United Kingdom.

Authors:  A Shenkin; G S Fell; D J Halls; P M Dunbar; I B Holbrook; M H Irving
Journal:  Clin Nutr       Date:  1986-05       Impact factor: 7.324

2.  Elevated serum chromium in patients on total parenteral nutrition and the ionic species of contaminant chromium.

Authors:  F Y Leung; L V Galbraith
Journal:  Biol Trace Elem Res       Date:  1995-12       Impact factor: 3.738

3.  DNA polymerase arrest by adducted trivalent chromium.

Authors:  L C Bridgewater; F C Manning; E S Woo; S R Patierno
Journal:  Mol Carcinog       Date:  1994-03       Impact factor: 4.784

4.  Chromium deficiency during total parenteral nutrition.

Authors:  H Freund; S Atamian; J E Fischer
Journal:  JAMA       Date:  1979-02-02       Impact factor: 56.272

5.  Chromium content of total parenteral nutrition solutions.

Authors:  Y Ito; N W Alcock; M E Shils
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Nov-Dec       Impact factor: 4.016

6.  Chromium(III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication in vitro.

Authors:  E T Snow; L S Xu
Journal:  Biochemistry       Date:  1991-11-26       Impact factor: 3.162

Review 7.  Mechanisms of chromium carcinogenicity and toxicity.

Authors:  M D Cohen; B Kargacin; C B Klein; M Costa
Journal:  Crit Rev Toxicol       Date:  1993       Impact factor: 5.635

8.  In vitro studies on the DNA impairments induced by Cr(III) complexes with cellular reductants.

Authors:  B Gulanowski; M Cieślak-Golonka; K Szyba; J Urban
Journal:  Biometals       Date:  1994-04       Impact factor: 2.949

9.  Abnormal deposits of chromium in the pathological human brain.

Authors:  S Duckett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

10.  Kinetics of trace element chromium(III) in the human body.

Authors:  T H Lim; T Sargent; N Kusubov
Journal:  Am J Physiol       Date:  1983-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.